 
         
        
    E047: Dina Burkitbayeva: PsyMed Ventures
Female VC Lab
| Barbara Bickham | Rating 0 (0) (0) | 
| femalevclab.com | Launched: Mar 31, 2022 | 
| Season: 1 Episode: 47 | |
                            
                             Directories 
                        
                    
        
          
          
            Subscribe
          
        
      
    Support My Podcast 
                                                Female VC Lab
                     E047: Dina Burkitbayeva: PsyMed Ventures
                     
                         Mar 31, 2022,
                         Season 1,
                         Episode 47
                     
                     Barbara Bickham
                 Episode Summary
                     PsyMed Ventures is a $25m venture fund focused on cutting edge mental health treatments including psychedelic therapeutic, neurotechnology, precision psychiatry and digital therapeutics. PsyMed Ventures invests in pre-seed, seed and Series A round. A third of PsyMed's current portfolio companies are co-founded by female founders. PsyMed donates 4.19% (wink to Bicycle Day, the day LSD was invested) to indigenous communities and non-profits in psychedelics space.
                  SHARE EPISODE 
                 SUBSCRIBE
Episode Chapters
 
             
                    PsyMed Ventures is a $25m venture fund focused on cutting edge mental health treatments including psychedelic therapeutic, neurotechnology, precision psychiatry and digital therapeutics. PsyMed Ventures invests in pre-seed, seed and Series A round. A third of PsyMed's current portfolio companies are co-founded by female founders. PsyMed donates 4.19% (wink to Bicycle Day, the day LSD was invested) to indigenous communities and non-profits in psychedelics space.
                
              Give Ratings
                            0
                        Out of 5
                        0  Ratings
                    
                            
                                
                                
                                
                                
                                
                                (0)
                            
                            
                                                                    
                                                            
                        
                        
                            
                                
                                
                                
                                
                                
                                (0)
                            
                            
                                                                    
                                                            
                        
                        
                            
                                
                                
                                
                                
                                
                                (0)
                            
                            
                                                                    
                                                            
                        
                        
                            
                                
                                
                                
                                
                                
                                (0)
                            
                            
                                                                    
                                                            
                        
                        
                            
                                
                                
                                
                                
                                
                                (0)
                            
                            
                                                                    
                                                            
                        
                    Comments:
                     
                                         
                                        